ARTICLE | Company News
Cangene, Twinstrand deal
April 28, 2003 7:00 AM UTC
The companies partnered to develop antibody-based therapeutics for ricin exposure. The project will be funded by Canada's CBRN (chemical, biological, radiological or nuclear incidents) Research and Te...